Business
– Clal Biotechnology and Hyperion have agreed on an independent assessment of Andromeda’s Type 1 diabetes treatment. – Clal Biotechnology (TASE: CBI), managed...
Hi, what are you looking for?
Jewish Business News
Business
– The company recently reported positive results in its first pre-clinical trial for the treatment of ALS. – Israeli biotechnology company Kadimastem announces today...
Business
– Michael Faerm says such a move is unlikely and would not solve Teva’s growth problems. – Wells Fargo analyst Michael Faerm recommends that...
Business
– Zacks cites the company for its technology, products, and meeting its targets. The share of Bio-Light Israeli Life Sciences Investments Ltd....
Business
Israel’s MediValve, Ltd. announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire that were conducted...
Business
– A 50% reduction in adverse side-effects was reported with the three-times-a-week 40 mg MS injection. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Business
– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company...
Business
By Gali Weinreb and Shiri Habib-Valdhorn Hyperion says it has “uncovered evidence” that Andromeda falsified clinical trial results. Hyperion Therapeutics Inc. (Nasdaq: HPTX) has...
Business
Kamada Ltd. (Nasdaq: KMDA); TASE: KMDA) today confirmed the results of its initial trial published three and a half months ago. At that time,...
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported that asthma treatment reslizumab demonstrated clear levels of efficacy in achieving the primary endpoint...